Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· October 31, 2025

The Global Rare Earth Magnets Research Report 2026-2036: Strategic Positioning, Technology Capabilities, Production Capacity, and Development Initiatives

View original at finance.yahoo.com
The Global Rare Earth Magnets Research Report 2026-2036: Strategic Positioning, Technology Capabilities, Production Capacity, and Development Initiatives Company Logo China's export controls on rare earth magnets have caused significant supply chain volatility, particularly affecting defense systems, electric vehicles,…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Global rare earth magnet demand approaches 385,000 tonnes annually in 2025, valued at approximately $19 billion

    80% confidence
  • The humanoid robotics sector alone could require massive magnet quantities as production scales toward potential deployment of billions of units

    80% confidence
  • Near-term demand growth from electrification continues to outpace substitution efforts despite demand destruction risk from technological substitution

    80% confidence
  • Developing complete alternatives to Chinese rare earth capabilities will require years rather than months, given complex separation and processing technologies

    80% confidence
  • Robotics is forecast to become the single largest driver of NdFeB magnet consumption by 2040, driven by professional service robots

    80% confidence
  • The rare earth magnet market has compound annual growth of 7.8% driven primarily by automotive electrification and renewable energy deployment

    80% confidence
  • Market fundamentals remain exceptionally strong despite supply disruptions

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
The Global Rare Earth Magnets Research Report 2026-2036: Strategic Positioning, Technology Capabilities, Production Capacity, and Development Initiatives — Source | Via News | Via News